Flora Growth Announces Results of 2024 Annual and Special Meeting of Shareholders
Flora Growth Announces Results of 2024 Annual and Special Meeting of Shareholders
Fort Lauderdale, Florida--(Newsfile Corp. - August 14, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") held its 2024 Annual and Special Meeting of Shareholders (the "Annual Meeting"). The final voting results of the proposals submitted to a vote of the Company's shareholders at the Annual Meeting are as follows:
佛罗里达州劳德代尔堡--(Newsfile Corp. - 2024年8月14日)- Flora Growth Corp.(NASDAQ:FLGC)(FSE:7301)(下称“Flora”或“公司”)举行了2024年股东年会和特别会议(“年会”)。公司股东在年会上进行表决的提案的最终投票结果如下:
Proposal 1: Election of four directors to the Board of Directors of the Company (the "Board") to hold office until the Company's 2025 Annual Meeting of Shareholders or until their respective successors are elected or appointed:
提案1:选举四名董事进入公司董事会(称为“ 董事会”),担任其职务,直到公司2025年股东大会或选举或任命其各自的继任者为止:
Broker | ||||||||
Director | For | Against | Abstentions | Non-Votes | ||||
Clifford Starke | 4,969,741 | 97,612 | 18,969 | 2,778,760 | ||||
Kevin Taylor | 4,931,118 | 129,648 | 25,556 | 2,778,760 | ||||
Edward Woo | 4,881,581 | 179,654 | 25,087 | 2,778,760 | ||||
Brendan Cahill | 5,001,476 | 57,680 | 27,166 | 2,778,760 |
代理 | ||||||||
董事 | 赞成 | 反对 | 代理商未投票的影响 | 未投票股份 | ||||
Clifford Starke | 4,969,741 | 97,612 | 18,969 | 2,778,760 | ||||
Kevin Taylor | 4,931,118 | 129,648 | 25,556 | 2,778,760 | ||||
Edward Woo | 4,881,581 | 179,654 | 25,087 | 2,778,760 | ||||
Brendan Cahill | 5,001,476 | 57,680 | 27,166 | 2,778,760 |
Proposal 2: Reappointment of Davidson & Company LLP, an independent registered public accounting firm, as auditors of the Company for the fiscal year ending December 31, 2024 and authorization of the Board to fix their renumeration.
提案2:重新委任Davidson & Company LLP为公司独立注册会计师事务所,担任截至2024年12月31日的财政年度审计师,并授权董事会确定其酬金。
For | Against | Abstentions | ||||
7,499,363 | 323,623 | 42,096 |
赞成 | 反对 | 代理商未投票的影响 | ||||
7,499,363 | 323,623 | 42,096 |
Proposal 3: Approval of an amendment to the Company's 2022 Incentive Compensation Plan to increase the number of shares issuable thereunder from 950,000 to 2,500,000 shares.
提案3:批准对公司2022年激励计划的修订,将可发行股票数量从950,000股增加至2,500,000股。
Broker | ||||||||
For | Against | Abstentions | Non-Votes | |||||
4,776,425 | 285,446 | 24,451 | 2,778,760 |
代理 | ||||||||
赞成 | 反对 | 代理商未投票的影响 | 未投票股份 | |||||
4,776,425 | 285,446 | 24,451 | 2,778,760 |
Proposal 4: Approval of the grant of stock appreciation rights of the Company to the Company's Chief Executive Officer and Chief Financial Officer.
提案4批准向公司首席执行官和致富金融官授予公司股票增值权。
Broker | ||||||||
For | Against | Abstentions | Non-Votes | |||||
4,802,189 | 253,288 | 30,845 | 2,778,760 |
代理 | ||||||||
赞成 | 反对 | 代理商未投票的影响 | 未投票股份 | |||||
4,802,189 | 253,288 | 30,845 | 2,778,760 |
Proposal 5: Approval of the issuance of 635,363 shares in accordance with Nasdaq Listing Rule 5635(a) to acquire the minority interest of TruHC Pharma GmbH.
第5项提案根据纳斯达克第5635(a)条目,批准发行635,363股股份,以收购TruHC Pharma GmbH的少数股权。
Broker | ||||||||
For | Against | Abstentions | Non-Votes | |||||
4,249,883 | 184,837 | 26,704 | 2,778,760 |
代理 | ||||||||
赞成 | 反对 | 代理商未投票的影响 | 未投票股份 | |||||
4,249,883 | 184,837 | 26,704 | 2,778,760 |
No other matters were considered or voted upon at the Annual Meeting.
年度股东大会未考虑或表决其他事项。
About Flora Growth Corp.
关于Flora Growth Corp。
Flora Growth Corp. is a consumer-packaged goods leader and pharmaceutical distributor serving all 50 states and 28 countries with 20,000+ points of distribution around the world. For more information on Flora, visit .
Flora Growth Corp.是一家消费品包装领先公司和药品分销商,在全球50个州和28个国家拥有20,000多个分销点。有关Flora的更多信息,请访问 。
Investor Relations:
投资者关系:
Investor Relations ir@floragrowth.com
Clifford Starke Clifford.Starke@floragrowth.com
投资者关系 ir@floragrowth.com
克利福德·斯塔克 Clifford.Starke@floragrowth.com
Media:
媒体:
media@floragrowth.com
媒体@floragrowth.com
Cautionary Statement Concerning Forward-Looking Statements
关于前瞻性声明的警示性声明
This press release may contain "forward-looking statements," as defined by U.S. federal securities laws. Forward-looking statements reflect Flora's current expectations and projections about future events at the time, and thus involve uncertainty and risk. The words "believe," "expect," "anticipate," "will," "could," "would," "should," "may," "plan," "estimate," "intend," "predict," "potential," "continue," and the negatives of these words and other similar expressions generally identify forward-looking statements. Such forward-looking statements are subject to various and risks and uncertainties, including those described under section entitled "Risk Factors" in Flora's Annual Report on Form 10-K filed with the United States Securities and Exchange Commission (the "SEC") on March 28, 2024, as such factors may be updated from time to time in Flora's periodic filings with the SEC, which are accessible on the SEC's website at www.sec.gov/edgar. Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this release and in Flora's filings with the SEC. While forward-looking statements reflect Flora's good faith beliefs, they are not guarantees of future performance. Flora disclaims any obligation to publicly update or revise any forward-looking statement to reflect changes in underlying assumptions or factors, new information, data or methods, future events or other changes after the date of this press release, except as required by applicable law. You should not place undue reliance on any forward-looking statements, which are based on information currently available to Flora (or to third parties making the forward-looking statements).
本新闻稿可能包含根据美国联邦证券法定义的“前瞻性陈述”。前瞻性陈述反映了Flora目前对未来事件的预期和展望,因此涉及不确定性和风险。诸如“相信”、“预期”、“预计”、“将”、“可能”、“愿意”、“应该”、“可能性”、“计划”、“估计”、“打算”、“预测”、“潜在”、“继续”以及这些词汇的否定和其他类似表达通常会确定前瞻性陈述。这些前瞻性陈述会受到各种风险和不确定性的影响,其中包括Flora在2024年3月28日提交给美国证券交易委员会(“SEC”)的年度10-k表格的“风险因素”下列明的风险因素,以及这些因素可能会不时在Flora向SEC提交的定期报告中进行更新,这些报告可在SEC的网站www.sec.gov/edgar上获得。因此,存在或将存在的重要因素可能会导致实际结果或结果与这些陈述所示有所不同。这些因素不应被解释为详尽无遗,并应与本发布中包含的其他谨慎声明以及Flora向SEC提交的备案文件一起阅读。虽然前瞻性陈述反映Flora的真诚信仰,但它们并不能保证未来的业绩。Flora不承诺公开更新或修订任何前瞻性陈述,以反映基本假设或因素的变化,新信息,数据或方法,未来的事件或其他变化,在本新闻稿发布日期之后,除非适用法律另有规定。您不应过度依赖任何前瞻性陈述,这些陈述基于Flora(或向前瞻性陈述的第三方)当前可用的信息。